Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer - van Dijk, T H; Tamas, K; Beukema, J C (Ann Oncol, 2013)
, et al.